Bicycle Therapeutics Plc - ADR
BCYC
Market Cap$577.15M
Close$
$-2.25
127.8% downside
Current Fair Value
127.8% downsideOvervalued by 127.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $577.15 Million |
|---|---|
| Enterprise Value | $-200,692,359.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.29 |
| Beta | 1.4 |
| Outstanding Shares | 69,196,945 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.84 |
|---|---|
| PEG | -156.71 |
| Price to Sales | - |
| Price to Book Ratio | 0.81 |
| Enterprise Value to Revenue | -5.44 |
| Enterprise Value to EBIT | 0.94 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.08 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bicycle Therapeutics Plc
CEO: Kevin Lee